The Medicon Valley biotech industry has matured to such an extent that an impressive 11 companies are considering an IPO within the coming three years.
According to an investigation from Sunstone Capital the stock exchange will be crowded in the coming years. Medicon Valley biotech is doing so well that 3 companies are planning an IPO in 2008, 6 companies expect an IPO in 2009 and at least 2 companies are heading towards an IPO in 2010.
A big part of the companies will be Danish, but the IPO's will also include Swedish companies. To this Peter Benson, Managing Partner in Sunstone Capital, comments that there is a greater optimism in Denmark where the last years of biotech success has created a positive spiral of success and optimism. In Sweden more companies have faced problems and Peter Benson states that the investors' will to invest in that part of the region is lower.
The investigation from Sunstone Capital has been carried out anonymously among biotech CEO's and Board members in Medicon Valley.
Read more at www.business.dk (in Danish)